Pfizer plans to invest $1 billion in China by 2030 to support innovation, diagnostics, and the biotech sector, aligning with ...

Viracta Therapeutics has announced a restructuring to focus on its lead oncology candidate, nana-val, targeting EBV-positive ...

AlloVir will merge with Kalaris Therapeutics in an all-stock transaction, with Kalaris shareholders holding a 75% stake in ...

US mRNA specialist Moderna today announced Health Canada has approved mRESVIA (respiratory syncytial virus mRNA vaccine) for active immunization for the prevention of lower respiratory tract disease ...

Indian markets are abuzz with a singular refrain. Donald Trump's Presidency of the United States is set to open new ...

GEN1047, GEN3017, and GEN1056—to refocus resources, following its recent $1.8 billion acquisition of ProfoundBio. The move ...

Japanese ophthalmology company Santen Pharmaceutical has crossed the East China Sea in its latest collaboration, announced on ...

US generic drugmaker Viatris (Nasdaq: VTRS) announced robust financial results for the third quarter of 2024, driven by ...

Dizal has submitted an application to the US FDA for sunvozertinib, an oral EGFR inhibitor for advanced NSCLC with EGFR exon ...

Italian pharma major Recordati saw its shares dip 3.75% to 50.10 euros this morning, despite posting a set of strong financial results. Consolidated net revenue for the first nine months of 2024 was 1 ...

A review has found that complexities and inefficiencies within the UK’s health data infrastructure are hindering the ...

US healthcare giant Johnson & Johnson today revealed it has submitted applications with the US Food and drug Administration ...